These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12168828)

  • 1. Effects of gossypol on O2 consumption and CO2 production in human prostate cancer cells.
    Jiang J; Ghosh PK; Kulp SK; Sugimoto Y; Liu S; Czekajewski J; Chang HL; Lin YC
    Anticancer Res; 2002; 22(3):1491-6. PubMed ID: 12168828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
    Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gossypol inhibits human chorionic gonadotropin-stimulated testosterone production by cultured canine testicular interstitial cells.
    Mushtaq M; Kulp S; Chang W; Lin YC
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):259-72. PubMed ID: 8829766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
    Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
    Jiang J; Ye W; Lin YC
    Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
    Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
    Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.
    Jiang J; Kulp SK; Sugimoto Y; Liu S; Lin YC
    Anticancer Res; 2000; 20(6B):4591-7. PubMed ID: 11205308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
    Davoodpour P; Landström M; Welsh M
    BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer.
    Schnier JB; Nishi K; Gumerlock PH; Gorin FA; Bradbury EM
    BMC Urol; 2005 Mar; 5():6. PubMed ID: 15790394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
    Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
    J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta.
    Shidaifat F; Canatan H; Kulp SK; Sugimoto Y; Chang WY; Zhang Y; Brueggemeier RW; Somers WJ; Lin YC
    Cancer Lett; 1996 Oct; 107(1):37-44. PubMed ID: 8913264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
    Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
    Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
    Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells.
    Kim DK; Yang JS; Maiti K; Hwang JI; Kim K; Seen D; Ahn Y; Lee C; Kang BC; Kwon HB; Cheon J; Seong JY
    Cancer Res; 2009 Feb; 69(3):923-31. PubMed ID: 19176390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
    Bonaccorsi L; Marchiani S; Ferruzzi P; Muratori M; Crescioli C; Forti G; Maggi M; Baldi E
    Steroids; 2006 Apr; 71(4):304-9. PubMed ID: 16289173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?
    Siddiqui EJ; Shabbir M; Thompson CS; Mumtaz FH; Mikhailidis DP
    Anticancer Res; 2005; 25(6B):4281-6. PubMed ID: 16309229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines.
    Chowdhury SK; Gemin A; Singh G
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1139-45. PubMed ID: 15967408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.